A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011
Active, not recruiting · NCT07295496 · Registry updated 2026-05-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011 | Acute Gout Flare | Active, not recruiting | Phase 1 | 2026-05-27 | NCT07295496 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | China | 101 |